NCT04409925View on ClinicalTrials.gov

DISmantling COvid iNduced Neutrophil ExtraCellular Traps (DISCONNECT-1)

PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

December 25, 2020

Primary Completion Date

April 1, 2021

Study Completion Date

August 1, 2021

Conditions
COVID-19 Infection
Interventions
DRUG

rhDNase I

Inhaled nebulisations

Trial Locations (2)

L8L 2X2

Hamilton General Hospital, Hamilton Health Sciences, Hamilton

H4A 3J1

McGill University Health Centre, Montreal

Sponsors

Collaborators (1)

Exactis Innovation
All Listed Sponsors
collaborator

Hamilton Health Sciences Corporation

OTHER

collaborator

Hoffmann-La Roche

INDUSTRY

collaborator

Exactis Innovation

OTHER

lead

McGill University Health Centre/Research Institute of the McGill University Health Centre

OTHER

NCT04409925 - DISmantling COvid iNduced Neutrophil ExtraCellular Traps (DISCONNECT-1) | Biotech Hunter | Biotech Hunter